Lymph node metastasis probability in young patients eligible for conservative management of endometrial cancer.


Journal

Gynecologic oncology
ISSN: 1095-6859
Titre abrégé: Gynecol Oncol
Pays: United States
ID NLM: 0365304

Informations de publication

Date de publication:
04 2020
Historique:
received: 07 08 2019
revised: 27 01 2020
accepted: 13 02 2020
pubmed: 7 3 2020
medline: 7 10 2020
entrez: 7 3 2020
Statut: ppublish

Résumé

Endometrial cancer (EC) is a rare condition in young women. The objective of this study was to evaluate the risk of pelvic lymph node (LN) metastasis in young women with EC who are candidates for conservative management. Using the SEER database, a population-based analysis was conducted to identify women <45 years with grade 1, 2, or 3 endometrioid adenocarcinoma stage IA (FIGO 2009) who underwent pelvic lymphadenectomy with at least ten LNs removed. The LN macrometastases rate based on conventional histological diagnosis was analyzed according to tumor grade and myometrial invasion (MI) on final histology. A cohort of 1284 women was analyzed. The LN metastasis rates were: 2/414 (0.5%) grade 1 EC without MI, 5/239 (2.1%) grade 2 or 3 EC without MI, 5/308 (1.6%) grade 1 EC with MI, and 14/323 (4.3%) grade 2 or 3 EC with MI. Tumor size was not correlated with LN metastasis probability. Young patients eligible for conservative management have a low rate of LN macrometastasis, especially in stage IA without MI grade 1 EC. A systematic lymphadenectomy should not be performed in these patients. Prospective study evaluating the sentinel LN mapping in conservative management of EC could be performed to assess the LN micrometastasis rate.

Identifiants

pubmed: 32139150
pii: S0090-8258(20)30157-8
doi: 10.1016/j.ygyno.2020.02.021
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

131-135

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Each author believes that the manuscript represents honest work and none of them has conflict of interest between themselves and others.

Auteurs

Clémentine Gonthier (C)

Department of Gynecologic Oncology, Bichat University Hospital, Paris, France; PREFERE Center, French referent center in conservative management of endometrial cancer, Bichat University Hospital, Paris, France. Electronic address: clementinegonthier@hotmail.com.

Daria Douhnai (D)

Department of Gynecologic Oncology, Bichat University Hospital, Paris, France.

Martin Koskas (M)

Department of Gynecologic Oncology, Bichat University Hospital, Paris, France; PREFERE Center, French referent center in conservative management of endometrial cancer, Bichat University Hospital, Paris, France; Paris Diderot University Paris 07, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH